Schedule 13G ownership disclosure
Corbus Pharmaceuticals Holdings, Inc.
Security class unavailable · CUSIP: 21833P103
Event date: 2020-04-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,632,418
- Percent of class
- 5.0100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-010018
- Form type
- SC 13G
- Filer
- Corbus Pharmaceuticals Holdings, Inc.
- CIK
- CIK 1595097
- Filed
- Apr 24, 2020
- Reporting period
- Apr 23, 2020
- Description
- Schedule 13G beneficial ownership